CAS No. |
49842-07-1 |
英文名称 |
(2S,3R,4S,5S,6R)-4-amino-2-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol sulfate |
别名 |
TOBRAMYCIN SULFATE SALT;TOBRAMYCIN SULPHATE;1-epitobramycinsulfate;d-6-trideoxy-alpha-d-ribohexopyranosyl-(1-4))-2-deoxysulfate(salt);obracine;streptamine,o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1-6)-o-(2,6-diamino-2,3,;tenemicin;O-[3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1→6)]-O-[2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1→4)]-2-deoxy-D-streptamine sulfate |
标准英文名 |
(2S,3R,4S,5S,6R)-4-amino-2-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol sulfate |
分子式 |
C18H39N5O13S |
分子量 |
565.60
|
精确分子量 |
565.23
|
SMILES |
NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O.O=S(=O)(O)O |
标准SMILES |
NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O.OS(O)(=O)=O |
用途 |
Tobramycin sulfate is a broad-spectrum aminoglycoside antibiotic administered parenterally, primarily used to treat moderate to severe bacterial infections caused by susceptible organisms. It is indicated for infections caused by Pseudomonas aeruginosa, Escherichia coli, Klebsiella species, Enterobacter species, indole-negative Proteus species, and Staphylococcus species, including neonatal sepsis, sepsis, central nervous system infections (including meningitis), urinary tract and genital infections, respiratory tract infections, biliary tract infections, intra-abdominal infections (including peritonitis), bone infections, burn wounds, skin and soft tissue infections, acute and chronic otitis media, and sinusitis. Tobramycin is ineffective against most Group D streptococcal infections. |
InChIKey |
ZEUUPKVZFKBXPW-TWDWGCDDSA-N |